Coriell Institute for Medical Research
Coriell Institute of Medical Research
  • Request a Quote
  • Donate
  • Login
  • View Cart
Sample Catalog | Custom Services | Core Facilities | Genomic Data Search
  • Biobank
    • NIGMS
    • NINDS
    • NIA
    • NHGRI
    • NEI
    • Allen Cell Collection
    • Rett Syndrome iPSC Collection
    • Autism Research Resource
    • HD Community Biorepository
    • CDC Cell and DNA
    • J. Craig Venter Institute
    • Orphan Disease Center Collection
    • All Biobanks
  • Research
    • Overview
    • Meet Our Scientists
      • Our Faculty
      • Our Scientific Staff
    • Camden Cancer Research Center
    • Epigenetic Therapies SPORE
    • Core Facilities
    • Epigenomics
    • Camden Opioid Research Initiative (CORI)
    • The Issa & Jelinek Lab
    • The Jian Huang Lab
    • The Luke Chen Lab
      • The Lab
      • The Team
      • Publications
    • The Scheinfeldt Lab
    • The Shumei Song Lab
    • The Nora Engel Lab
      • The Lab
      • The Team
      • Publications
    • Publications
  • Services
    • Overview
    • Biobanking Services
      • Core Services
      • Project Management
      • Research Support Services
      • Sample Cataloging
      • Sample Collection Kits
      • Sample Data Management
      • Sample Distribution
      • Sample Management
      • Sample Procurement
      • Sample Storage
    • Bioinformatics and Biostatistics Services
    • Cellular and Molecular Services
      • Biomarker Research Solutions
      • Cell Culture
      • Nucleic Acid Isolation and Quality Control
    • Clinical Trial Support
      • Overview
      • Sample Collection
      • Data Management
      • Sample Processing and QC
      • Storage and Distribution
      • Biomarker Services
      • Data Analaysis
    • Core Facilties
      • Overview
      • Animal and Xenograft
      • Bioinformatics and Biostatistics
      • Cell Imaging
      • CRISPR Gene Engineering
      • Flow Cytometry and Cell Sorting
      • Genomics and Epigenomics
      • iPSC - Induced Pluripotent Stem Cells
      • Organoids
    • Coriell Marketplace
    • Genomic, Epigenomic and Multiomics Services
    • Stem Cells and iPSC Services
      • Core Services
      • Reprogramming
      • Characterization and Quality Control
      • Differentiated Cell Lines
      • iPSC-Derived Organoids
      • iPSC Expansion
      • iPSC Gene Editing
  • Ordering
    • Stem Cells
    • Cell Lines
    • DNA and RNA
    • Featured Products
      • FFPE
      • HMW DNA
    • Genomic Data Search
    • Search by Catalog ID
    • Help
      • Create Account
      • Order Online
      • Ordering FAQ
      • FAQs/Culture Instructions
      • Reference Materials
        • Biobanks
        • NIGMS Repository
        • NHGRI Repository
        • NINDS Repository
        • NIA Repository
        • NIST
        • GeT-RM
      • Secondary Distribution Policies
      • MTA Assurance Form
      • Shipment Policy
      • Contact Customer Service
  • About Us
    • Our History
    • Meet Our Team
    • Meet Our Board
    • Education
      • Science Fair
      • Summer Experience
      • Outreach
      • Research Program Internship
    • Press Room
      • Press Releases
      • Coriell Blog
      • Annual Report
    • Careers
      • Working at Coriell
    • Giving
      • Donate
      • Giving FAQ
    • Contact Us
    • Legal Notice
  • Login View Cart
search submit
NG07086 DNA from Mesothelial

Description:

OVARIAN CANCER

Affected:

No

Sex:

Female

Age:

26 YR (At Sampling)

  • Overview
  • Characterizations
  • Phenotypic Data
  • Publications

Overview

back to top
Repository NIA Aging Cell Culture Repository
Subcollection Apparently Healthy Collection
Quantity 10 µg
Quantitation Method Please see our FAQ
Biopsy Source Ascites fluid
Cell Type Mesothelial
Tissue Type Peritoneum
Transformant Untransformed
Sample Source DNA from Mesothelial
Relation to Proband proband
Confirmation Clinical summary/Case history
Species Homo sapiens
Common Name Human
Remarks Normal human mesothelial cell strain LP-9. The culture was initiated on 10/1/83 by directly plating an ascites fluid cell suspension which had been stored frozen since removal from the peritoneal cavity of an ovarian cancer patient on 9/2/81. The culture medium must be supplemented with 10 nanograms/ml EGF and 0.4 micrograms/ml hydrocortisone. The cell morphology is fibroblast-like in medium supplemented with EGF, but is epithelial-like in medium without EGF. The karyotype is 46,XX; normal diploid female.***Must Ship Frozen*** The legacy karyotype description shown in this Remark may not be representative of the current available product.

Characterizations

back to top
PDL at Freeze 4.84
Passage Frozen 6
 
IDENTIFICATION OF SPECIES OF ORIGIN Species of Origin Confirmed by Chromosome Analysis
 

Phenotypic Data

back to top
Remarks Normal human mesothelial cell strain LP-9. The culture was initiated on 10/1/83 by directly plating an ascites fluid cell suspension which had been stored frozen since removal from the peritoneal cavity of an ovarian cancer patient on 9/2/81. The culture medium must be supplemented with 10 nanograms/ml EGF and 0.4 micrograms/ml hydrocortisone. The cell morphology is fibroblast-like in medium supplemented with EGF, but is epithelial-like in medium without EGF. The karyotype is 46,XX; normal diploid female.***Must Ship Frozen*** The legacy karyotype description shown in this Remark may not be representative of the current available product.

Publications

back to top
Sekine S, Takase S, Hayase R, Noritsugu K, Maemoto Y, Ichikawa Y, Ogawa K, Kondoh Y, Osada H, Yoshida M, Ito A, Identification of a derivative of the alkaloid emetine as an inhibitor of the YAP-TEAD interaction and its potential as an anticancer agent Bioscience, biotechnology, and biochemistry87:501-510 2023
PubMed ID: 36809780
 
Snell D, Gunde T, Warmuth S, Chatterjee B, Brock M, Hess C, Johansson M, Simonin A, Spiga FM, Weinert C, Kirk N, Bassler N, Campos Carrascosa L, Flückiger N, Heiz R, Wagen S, Giezendanner N, Alberti A, Yaman Y, Mahler D, Diem D, Lichtlen P, Urech D, An engineered T-cell engager with selectivity for high mesothelin-expressing cells and activity in the presence of soluble mesothelin Oncoimmunology12:2233401 2023
PubMed ID: 37456982
 
Hyldbakk A, Fleten KG, Snipstad S, Åslund AKO, Davies CL, Flatmark K, Mørch Y, Intraperitoneal administration of cabazitaxel-loaded nanoparticles in peritoneal metastasis models Nanomedicine : nanotechnology, biology, and medicine48:102656 2022
PubMed ID: 36646195
 
Micek HM, Rosenstock L, Ma Y, Hielsberg C, Montemorano L, Gari MK, Ponik SM, Kreeger PK, Model of collective detachment in high-grade serous ovarian cancer demonstrates that tumor spheroids produce ECM to support metastatic processes APL bioengineering7:016111 2022
PubMed ID: 36875739
 
Rivera M, Toledo-Jacobo L, Romero E, Oprea TI, Moses ME, Hudson LG, Wandinger-Ness A, Grimes MM, Agent-based modeling predicts RAC1 is critical for ovarian cancer metastasis Molecular biology of the cell33:ar138 2022
PubMed ID: 36200848
 
Hartono AB, Kang HJ, Shi L, Phipps W, Ungerleider N, Giardina A, Chen W, Spraggon L, Somwar R, Moroz K, Drewry DH, Burow ME, Flemington E, Ladanyi M, Lee SB, Salt-Inducible Kinase 1 is a potential therapeutic target in Desmoplastic Small Round Cell Tumor Oncogenesis11:18 2021
PubMed ID: 35443736
 
Herbert SL, Fick A, Heydarian M, Metzger M, Wöckel A, Rudel T, Kozjak-Pavlovic V, Wulff C, Establishment of the SIS scaffold-based 3D model of human peritoneum for studying the dissemination of ovarian cancer Journal of tissue engineering13:20417314221088514 2021
PubMed ID: 35340423
 
Sommerfeld L, Finkernagel F, Jansen JM, Wagner U, Nist A, Stiewe T, Müller-Brüsselbach S, Sokol AM, Graumann J, Reinartz S, Müller R, The multicellular signalling network of ovarian cancer metastases Clinical and translational medicine11:e633 2021
PubMed ID: 34841720
 
Lin LL, Makwana S, Chen M, Wang CM, Gillette LH, Huang TH, Burney RO, Nicholson BJ, Kirma NB, Cellular junction and mesenchymal factors delineate an endometriosis-specific response of endometrial stromal cells to the mesothelium Molecular and cellular endocrinology539:111481 2020
PubMed ID: 34624439
 
Smith RS, Odintsov I, Liu Z, Lui AJ, Hayashi T, Vojnic M, Suehara Y, Delasos L, Mattar MS, Hmeljak J, Ramirez HA, Shaw M, Bui G, Hartono AB, Gladstone E, Kunte S, Magnan H, Khodos I, De Stanchina E, La Quaglia MP, Yao J, Laé M, Lee SB, Spraggon L, Pratilas CA, Ladanyi M, Somwar R, Novel patient-derived models of desmoplastic small round cell tumor confirm a targetable dependency on ERBB signaling Disease models & mechanisms15:111481 2020
PubMed ID: 34841430
 
Barbarino M, Cesari D, Bottaro M, Luzzi L, Namagerdi A, Bertolino FM, Bellan C, Proietti F, Somma P, Micheli M, de Santi MM, Guazzo R, Mutti L, Pirtoli L, Paladini P, Indovina P, Giordano A, PRMT5 silencing selectively affects MTAP-deleted mesothelioma: In vitro evidence of a novel promising approach Journal of cellular and molecular medicine15:111481 2019
PubMed ID: 32301278
 
Bilandzic M, Rainczuk A, Green E, Fairweather N, Jobling TW, Plebanski M, Stephens AN, Keratin-14 (KRT14) Positive Leader Cells Mediate Mesothelial Clearance and Invasion by Ovarian Cancer Cells Cancers11:111481 2019
PubMed ID: 31443478
 
Gormley CA, Keenan BJ, Buczek-Thomas JA, Pessoa ACSN, Xu J, Monti F, Tabeling P, Holt RG, Nagy JO, Wong JY, Fibrin-Targeted Polymerized Shell Microbubbles as Potential Theranostic Agents for Surgical Adhesions Langmuir : the ACS journal of surfaces and colloids11:111481 2019
PubMed ID: 30681875
 
Zhang L, Singh A, Plaisier C, Pruett N, Ripley RT, Schrump DS, Hoang CD, Metadherin Is a Prognostic Apoptosis Modulator in Mesothelioma Induced via NF-?B-Mediated Signaling Translational oncology12:859-870 2019
PubMed ID: 31054476
 
Cömertpay S, Gül Özçelik Demirbanka F, Lowered Cyclin E levels increase the efficiency and the specificity of capsaicin against cancerous cells of mesothelium Cellular and molecular biology (Noisy-le-Grand, France)66:98-104 2018
PubMed ID: 33040793
 
Knudtson JF, McLaughlin JE, Santos MT, Binkley PA, Tekmal RR, Schenken RS, The Hyaluronic Acid System is Intact in Menstrual Endometrial Cells in Women With and Without Endometriosis Reproductive sciences (Thousand Oaks, Calif)66:1933719118766257 2018
PubMed ID: 29621955
 
Jacobson BA, Thumma SC, Jay-Dixon J, Patel MR, Dubear Kroening K, Kratzke MG, Etchison RG, Konicek BW, Graff JR, Kratzke RA, Targeting eukaryotic translation in mesothelioma cells with an eIF4E-specific antisense oligonucleotide PLoS One8(11):e81669 2013
PubMed ID: 24260583
 
Koo YH, Na YJ, Ahn MY, Jeon HN, Yeom JI, Lee KS, Expression of CD44 in endometrial stromal cells from women with and without endometriosis and its effect on the adherence to peritoneal mesothelial cells Obstet Gynecol Sci56(2):102-9 2013
PubMed ID: 24327988
 
Kim M, Rooper L, Xie J, Kajdacsy-Balla AA, Barbolina MV., Fractalkine receptor CX(3)CR1 is expressed in epithelial ovarian carcinoma cells and required for motility and adhesion to peritoneal mesothelial cells. Mol Cancer Res10:11-24 2012
PubMed ID: 22064656
 
Ren J, Xiao YJ, Singh LS, Zhao X, Zhao Z, Feng L, Rose TM, Prestwich GD, Xu Y, Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells Cancer research66:3006-14 2006
PubMed ID: 16540649
 
Burleson KM, Boente MP, Pambuccian SE, Skubitz AP, Disaggregation and invasion of ovarian carcinoma ascites spheroids Journal of translational medicine [electronic resource]4:6 2005
PubMed ID: 16433903
 
Burleson KM, Hansen LK, Skubitz AP, Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers Clinical & experimental metastasis21:685-97 2005
PubMed ID: 16035613
 
Lucidi RS, Witz CA, Chrisco M, Binkley PA, Shain SA, Schenken RS, A novel in vitro model of the early endometriotic lesion demonstrates that attachment of endometrial cells to mesothelial cells is dependent on the source of endometrial cells. Fertil Steril84(1):16-21 2005
PubMed ID: 16009148
 
Kanerva A, Bauerschmitz GJ, Yamamoto M, Lam JT, Alvarez RD, Siegal GP, Curiel DT, Hemminki A, A cyclooxygenase-2 promoter-based conditionally replicating adenovirus with enhanced infectivity for treatment of ovarian adenocarcinoma Gene therapy11:552-9 2004
PubMed ID: 14999227
 
Casey RC, Oegema TR, Skubitz KM, Pambuccian SE, Grindle SM, Skubitz AP, Cell membrane glycosylation mediates the adhesion, migration, and invasion of ovarian carcinoma cells Clinical & experimental metastasis20:143-52 2003
PubMed ID: 12705635
 
Kanerva A, Wang M, Bauerschmitz GJ, Lam JT, Desmond RA, Bhoola SM, Barnes MN, Alvarez RD, Siegal GP, Curiel DT, Hemminki A, Gene transfer to ovarian cancer versus normal tissues with fiber-modified adenoviruses. Mol Ther5(6):695-704 2002
PubMed ID: 12027553
 
Casado E, Gomez-Navarro J, Yamamoto M, Adachi Y, Coolidge CJ, Arafat WO, Barker SD, Wang MH, Mahasreshti PJ, Hemminki A, Gonzalez-Baron M, Barnes MN, Pustilnik TB, Siegal GP, Alvarez RD, Curiel DT, Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applications. Clin Cancer Res7(8):2496-504 2001
PubMed ID: 11489832
 
Lee TC, Zhang Y, Aston C, Hintz R, Jagirdar J, Perle MA, Burt M, Rom WN, Normal human mesothelial cells and mesothelioma cell lines express insulin-like growth factor I and associated molecules. Cancer Res53:2858-64 1993
PubMed ID: 7684950
 
La Rocca PJ, Rheinwald JG, Anchorage-independent growth of normal human mesothelial cells: a sensitive bioassay for EGF which discloses the absence of this factor in fetal calf serum. In Vitro Cell Dev Biol21:67-72 1985
PubMed ID: 3878841
 
LaRocca PJ, Rheinwald JG, Coexpression of simple epithelial keratins and vimentin by human mesothelium and mesothelioma in vivo and in culture. Cancer Res44:2991-9 1984
PubMed ID: 6202404
 
Connell ND, Rheinwald JG, Regulation of the cytoskeleton in mesothelial cells: reversible loss of keratin and increase in vimentin during rapid growth in culture. Cell34:245-53 1983
PubMed ID: 6192933
Pricing
Commercial:
$155.00USD
Academic &
Non-profit:
$72.00USD
NIA Grantees:
$62.00USD
Add to Cart
How to Order
  • Ordering Instructions
  • MTA / Assurance Form
  • Statement of Research Intent Form
Related Products
Same Subject
  • AG07086 - Mesothelial
Miscellaneous
  • Custom Services

Our mission is to prevent and cure disease through biomedical research.

CONTACT US

CUSTOMER SERVICE
customerservice@coriell.org (800) 752-3805 • (856) 757-4848
Subscribe to our newsletter here

Coriell Institute for Medical Research
403 Haddon Avenue Camden, NJ 08103, USA (856) 966-7377

Ⓒ 2025 Coriell Institute. All rights reserved.

  • Facebook
  • Linkedin
  • Youtube